Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma

C. Mariette, F. Carneiro, H. I. Grabsch, R. S. van der Post, W. Allum, Giovanni de Manzoni*, European Chapter of International Gastric Cancer Association

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

66 Citations (Web of Science)

Abstract

Background and aimsClinicopathological characteristics of gastric cancer (GC) are changing, especially in the West with a decreasing incidence of distal, intestinal-type tumours and the corresponding increasing proportion of tumours with Lauren diffuse or WHO poorly cohesive (PC) including signet ring cell (SRC) histology. To accurately assess the behaviour and the prognosis of these GC subtypes, the standardization of pathological definitions is needed.MethodsA multidisciplinary expert team belonging to the European Chapter of International Gastric Cancer Association (IGCA) identified 11 topics on pathological classifications used for PC and SRC GC. The topics were debated during a dedicated Workshop held in Verona in March 2017. Then, through a Delphi method, consensus statements for each topic were elaborated.ResultsA consensus was reached on the need to classify gastric carcinoma according to the most recent edition of the WHO classification which is currently WHO 2010. Moreover, to standardize the definition of SRC carcinomas, the proposal that only WHO PC carcinomas with more than 90% poorly cohesive cells having signet ring cell morphology have to be classified as SRC carcinomas was made. All other PC non-SRC types have to be further subdivided into PC carcinomas with SRC component (10% SRCs) and PC carcinomas not otherwise specified (

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalGastric Cancer
Volume22
Issue number1
DOIs
Publication statusPublished - Jan 2019

Keywords

  • Gastric cancer
  • Poorly cohesive sub-type
  • Signet ring cell histology
  • RING CELL-CARCINOMA
  • PROGNOSTIC-SIGNIFICANCE
  • HISTOLOGIC-TYPE
  • UNITED-STATES
  • DIFFUSE TYPES
  • MIXED-TYPE
  • ESOPHAGEAL
  • CANCER
  • REGRESSION
  • CHEMORADIOTHERAPY

Cite this